IGC Pharma (IGC) Interest Expenses (2010 - 2017)
IGC Pharma (IGC) reported Interest Expenses of $60527.0 for Q4 2017, up 30.26% year-over-year from $46465.0 in Q4 2016, and up 48.23% quarter-over-quarter from $40832.0 in Q3 2017.
IGC Pharma (IGC) Interest Expenses (2010 - 2017) Analysis & Trends
IGC Pharma (IGC) has 8 years of Interest Expenses data on file, last reported at $60527.0 in Q4 2017.
- Interest Expenses for Q4 2017 came in at $60527.0, up 30.26% year-over-year; the trailing twelve-month figure through Sep 2018 was $60527.0 (down 72.35% YoY), and the FY2017 annual result was $223464.0, up 4.46% from the prior year.
- Interest Expenses climbed to $60527.0 in Q4 2017 per IGC's latest filing, from $40832.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $504932.0 in Q1 2013 and troughed at $33928.0 in Q1 2016.
- A 5-year average of $83559.4 and a median of $60848.5 in 2014 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2013 and 2014: Interest Expenses surged 1880.46% in 2013, then tumbled 88.5% in 2014.
- A 5-year view of Interest Expenses shows it stood at $52502.0 in 2013, then climbed by 18.01% to $61957.0 in 2014, then fell by 17.68% to $51000.0 in 2015, then dropped by 8.89% to $46465.0 in 2016, then soared by 30.26% to $60527.0 in 2017.
- Business Quant data shows IGC's Interest Expenses at $60527.0 in Q4 2017, $40832.0 in Q3 2017, and $44546.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -5.58 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 60,527.00 |
| Dec 31, 2017 | 60,527.00 |
| Sep 30, 2017 | 40,832.00 |
| Sep 30, 2017 | 40,832.00 |
| Jun 30, 2017 | 44,546.00 |
| Jun 30, 2017 | 44,546.00 |
| Mar 31, 2017 | 87,043.00 |
| Mar 31, 2017 | 87,043.00 |
| Dec 31, 2016 | 46,465.00 |
| Dec 31, 2016 | 46,465.00 |
| Sep 30, 2016 | 51,410.00 |
| Sep 30, 2016 | 51,410.00 |
| Jun 30, 2016 | 43,278.00 |
| Jun 30, 2016 | 43,278.00 |
| Mar 31, 2016 | 33,928.00 |
| Mar 31, 2016 | 33,928.00 |
| Dec 31, 2015 | 51,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Sep 30, 2015 | 67,460.00 |
| Sep 30, 2015 | 67,460.00 |